Discover how Constructive Bio is building beyond nature to create the next generation of biomolecules. Using synthetic genomes and non-canonical amino acids, this UK-based biotech is developing therapeutics with enhanced molecular and chemical properties. Just look at drugs like Wegovy and Ozempic — their active ingredient semaglutide incorporates a non-canonical amino acid to improve drug stability. Now imagine how this technology will expand the toolkit available not only for drug development, but across industries. With Constructive’s ability to design molecules with unprecedented specificity and fidelity, they’re unlocking the next generation of biologics — and doing so in a more sustainable and scalable way. See how they’re using Benchling to centralize their data and scale their R&D. We’re proud to support their mission! 🧬🧑🔬 https://lnkd.in/emjEFqAz #BuiltOnBenchling
Benchling’s Post
More Relevant Posts
-
Constructive Bio is pushing the boundaries of synthetic biology, and Benchling has been a key partner in this journey. Their platform helps us manage complex data and streamline workflows as we scale genome writing and engineered translation. Learn how we’re pioneering the future of biology:
Discover how Constructive Bio is building beyond nature to create the next generation of biomolecules. Using synthetic genomes and non-canonical amino acids, this UK-based biotech is developing therapeutics with enhanced molecular and chemical properties. Just look at drugs like Wegovy and Ozempic — their active ingredient semaglutide incorporates a non-canonical amino acid to improve drug stability. Now imagine how this technology will expand the toolkit available not only for drug development, but across industries. With Constructive’s ability to design molecules with unprecedented specificity and fidelity, they’re unlocking the next generation of biologics — and doing so in a more sustainable and scalable way. See how they’re using Benchling to centralize their data and scale their R&D. We’re proud to support their mission! 🧬🧑🔬 https://lnkd.in/emjEFqAz #BuiltOnBenchling
-
-
CEO at Evitria | Innovating in the Production of Antibodies | Expertise in Bioprocessing, Biopharmaceuticals and Lifesciences
This mindset is key to success in the biotechnology sector. Scientific breakthroughs and innovation are built on the back of failure. Over 100 bispecific antibodies are currently in clinical development, but just 14 have been approved since 2009. If we only began development when we could guarantee success, not a single antibody would have been approved. #Failure #Mindset #Biotechnology #BusinessInnovation
-
-
Struggling with preclinical bioanalysis bottlenecks? 🧪 Watch our on-demand webinar featuring real-world case studies from Charles River Laboratories: https://lnkd.in/gTW6UANG #Biotech #Bioanalysis #pharmacokinetics
-
-
Do you want to know more about the latest in oligonucleotide research? Explore our extensive library of educational videos. Discover the latest trends and breakthroughs. Learn from top researchers and experts in the field. Start learning today: https://lnkd.in/gn9pdUs3 #ots #oligotherapeutics #oligonucleotide #biotech #biotechnology #science #research #pharmaceuticals #networking #otsmember #educationalvideos #currentresearch #educationalvideos #educationalresources
-
-
Arktos Life Sciences: Pioneering Process Development for Complex Proteins Arktos Life Sciences specializes in process development and early-phase production of novel, hard-to-produce proteins. We are committed to pushing the boundaries of protein synthesis, ensuring high efficiency and enhanced efficacy in manufacturing challenging biomolecules. Our capabilities include advanced protein synthesis platforms for key proteins, such as CRISPR-Cas9. We leverage cutting-edge technology and deep expertise to optimize production processes that meet the rigorous demands of modern biotechnology and pharmaceutical applications. Stay tuned for the official launch of Arktos Life Sciences, where innovation meets precision in biomanufacturing. Follow us for updates and insights into our journey to transform the future of protein engineering! #Biotechnology #ProteinSynthesis #CRISPR #Biomanufacturing #Innovation
-
Transform your drug discovery process with the latest innovations in flow cytometry: https://lnkd.in/gQ67HFNR Get your hands on our detailed infographic to learn how to boost sample processing speeds and enhance data analysis. Don't miss out, download now! #Biotechnology #Biopharma #Research #FlowCytometry #DrugDiscovery
-
-
My recent perspective on post-pandemic #biotech #leapfrogging in Trends in Biotechnology (2024). Here is the link for fellow fans of biotech stocks: https://lnkd.in/grmFZQ7A Trends in Biotechnology
Global biotechnology leapfrogging during the COVID-19 pandemic: a trend to stay?
cell.com
-
Want to know more about what we do? 🤔 Check out the document below to read a case study into one of our latest projects. We supported a leading Biotechnology company with the project management and CQV of a state-of-the-art 250,000 sq. ft. greenfield manufacturing facility for monoclonal antibody production. ______________ Got a project to scope in? Contact us today to find out how we can help with your business needs! #iPharmGxP #biotechnology #casestudy
-
🚩 You can, now, streamline your manufacturing process and improve production to accelerate your biotherapeutic pipeline! How? With the CHOSOURCE™ expression platform from Horizon Discovery. 🎯 The CHOSOURCE™ expression platform from Horizon Discovery enables rapid identification of clones expressing high levels of recombinant therapeutic protein while developing a stable cell line. Here’s why it stands out: 🌟 Proven Industry Standard: Widely adopted with over 100 licenses sold since 2016. Over 60 global regulatory filings since 2018. Ability to reach high expression levels; customers routinely report > 5 g/L with different molecules. 🔧 Truly Adaptable: Validated with various feeds, media, processes, and vector technologies. Flexible licensing and pricing to meet your biomanufacturing needs. Uses the gold standard Glutamine Synthetase (GS) selection system. 👨🔬 Dedicated Support: Accessible sales, licensing, and scientific support teams. Extensive expertise to help drive advancements in your pipeline. 💡 Platform Components: CHOSOURCE GS knockout cell line: Robust, cGMP-manufactured using precision rAAV technology. Dual promoter expression vector: Enables the expression of an entire mAb from a single vector. Comprehensive protocols and support: Includes a cell line history package to support regulatory submissions. 👉 Contact us for more details. #bioproduction #biotherapeutics #pipeline #cellline #vector #biotech #biotechnology
-
-
BIO24 has concluded and the biotech executives are heading home. So are we, at Trailhead Biosystems. We thank all those we met, both those we planned to meet in advance but as much also those we met unexpectedly and learned from. Opportunities are everywhere - but only if we meet! BIO is an event that needs to be experienced - it is difficult to describe the intensity. The skies of future biotechnology are awaiting many new companies and cures. After BIO24 it feels as the turbulent time of the biotechnology sector is calming. That is good, as perfection takes time and continuity of focus gives results. If you think long acting Glp1R agonists came overnight, think again. Drugs, Biologics, and Cell Therapies are difficult. Very difficult. This industry takes Time. Commitment. Investment. Trailhead Biosystems #bio24 #cellandgenetherapy #trailbio #hddoe #biotechnology #t1d #hsct #futuremedicine #ipsc #biomanufacturing
-
